1 – 10 of 114
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Patient reported fatigue after proton therapy for malignant brain tumours – Is there a relation between radiation dose and brain structures?
(
- Contribution to journal › Article
-
Mark
Comparison of Self-Reported Physical Activity between Survivors of Out-of-Hospital Cardiac Arrest and Patients with Myocardial Infarction without cardiac arrest : a case-control study
(
- Contribution to journal › Article
-
Mark
Microstructure-Oriented Fatigue Crack Propagation in Two Cast Mg–Al–Ba–Ca Alloys
2025) Magnesium Technology Symposium, 2025, held as part of the TMS Annual Meeting and Exhibition, TMS 2025 In Minerals, Metals and Materials Series p.87-96(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Brain perfusion and blood-brain barrier permeability in systemic lupus erythematosus patients : Associations with disease activity, cognitive dysfunction, fatigue and pain
(
- Contribution to journal › Article
-
Mark
Qualitative study of fatigue in adults with primary mitochondrial disease : Development of the PROMIS Fatigue Mitochondrial Disease Short Form
(
- Contribution to journal › Article
- 2024
-
Mark
The Life After Stroke In Northern Sweden Study (LASINS) : Methodology, cohort demographics and initial results
(
- Contribution to journal › Article
-
Mark
Self-reported fatigue in people with post COVID-19 : Impact on functioning in daily life, and associated factors – a cross-sectional study
(
- Contribution to journal › Article
-
Mark
Multicriteria design of polymer gears according to VDI 2736 guideline
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Prospective evaluation of the relationship between cognition and recovery outcomes after cardiac arrest
(
- Contribution to journal › Article
-
Mark
A comparative study of fatigue and processing speed in patients with multiple sclerosis treated with natalizumab or rituximab
(
- Contribution to journal › Article